Induced pluripotent stem cells play vitally essential roles in regenerative medicines for disease modeling and drug screening. Here, we successfully generated an iPSC line from PBMC of a 60-year-old female with mild cognitive impairment in an APOE 4/4 background to better understand studies relating to MCI and other cognitive diseases. In the newly-developed hiPSC line SIAISi009-A, all pluripotent markers were well expressed. Moreover, cells displayed a normal karyotype and have differentiation potential proven by in vitro trilineage differentiation method.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.scr.2021.102198 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!